Breast cancer (BC) is one of the most malignant tumors and the leading cause of cancer-
related death in women worldwide. So, an in-depth investigation on the molecular …

Breast cancer is known to be a heterogeneous disease driven by a large repertoire of
molecular abnormalities, which contribute to its diverse clinical behaviour. Despite the …

Objective Head and neck squamous cell carcinoma (HNSCC) is a prevalent cancer that
originates from the squamous cells. The role of the replication factor C subunit 3 (RFC3) in …

Serrated pathway colorectal cancers (CRCs) are characterised by a BRAF mutation and half
display microsatellite instability (MSI). The Wnt pathway is commonly upregulated in …

Simple Summary Classical cytogenetic studies in breast cancer have identified frequent
chromosomal aberrations that produce an increased gene copy number in chromosome 1q …

Background Cervical squamous cell carcinoma (SCC) is known to arise through
increasingly higher-grade squamous intraepithelial lesions (SILs) or cervical intraepithelial …

Lung cancer is a malignant tumor responsible for the highest mortality rate in humans. The
identification of novel functional genes is of great importance in the treatment of lung cancer …

Background Cervical cancer progresses through different stages: a long stage of
precancerous lesions, then high-grade squamous intraepithelial lesion (HSIL) stage in …

Molecular changes often precede clinical presentation of diseases and can be useful
surrogates with potential to assist in informed clinical decision making. Recent studies have …

Activating KRAS mutations drive colorectal cancer tumorigenesis and influence response to
anti‐EGFR‐targeted therapy. Despite recent advances in understanding Ras signaling …